Search
for
Sort by
Research 61–90 of 203
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Post-finasteride syndrome: An emerging clinical problem
- The placebo effect and randomized trials: analysis of conventional medicine
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- The pathophysiology of delayed ejaculation
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study
- Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
- The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- Common urologic diseases in older men and their treatment: how they impact fertility
- Post-finasteride syndrome – does it really exist?
- Pharmacokinetic Interaction of Finasteride With Tamsulosin Hydrochloride: An Open-label, Randomized, 3-period Crossover Study in Healthy Chinese Male Volunteers
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy